ZWJ Investment Counsel Inc. Invests $201,000 in Prestige Consumer Healthcare Inc. (NYSE:PBH)

ZWJ Investment Counsel Inc. acquired a new position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) in the third quarter, Holdings Channel reports. The fund acquired 2,791 shares of the company’s stock, valued at approximately $201,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. State Board of Administration of Florida Retirement System lifted its holdings in shares of Prestige Consumer Healthcare by 77.4% during the 1st quarter. State Board of Administration of Florida Retirement System now owns 25,221 shares of the company’s stock worth $1,830,000 after acquiring an additional 11,000 shares during the period. BNP Paribas Financial Markets lifted its holdings in Prestige Consumer Healthcare by 143.4% during the 1st quarter. BNP Paribas Financial Markets now owns 51,246 shares of the company’s stock valued at $3,718,000 after purchasing an additional 30,191 shares during the last quarter. Congress Asset Management Co. MA lifted its holdings in Prestige Consumer Healthcare by 12.5% during the 1st quarter. Congress Asset Management Co. MA now owns 764,013 shares of the company’s stock valued at $55,437,000 after purchasing an additional 84,757 shares during the last quarter. Lombard Odier Asset Management USA Corp bought a new position in Prestige Consumer Healthcare during the 2nd quarter valued at about $550,000. Finally, CANADA LIFE ASSURANCE Co lifted its holdings in Prestige Consumer Healthcare by 19.4% during the 1st quarter. CANADA LIFE ASSURANCE Co now owns 47,575 shares of the company’s stock valued at $3,453,000 after purchasing an additional 7,715 shares during the last quarter. 99.95% of the stock is owned by institutional investors.

Prestige Consumer Healthcare Trading Up 0.5 %

PBH opened at $72.30 on Friday. The company has a current ratio of 3.23, a quick ratio of 1.90 and a debt-to-equity ratio of 0.65. The stock has a market capitalization of $3.59 billion, a PE ratio of 17.34, a PEG ratio of 1.93 and a beta of 0.47. Prestige Consumer Healthcare Inc. has a 1-year low of $56.61 and a 1-year high of $75.80. The firm has a 50-day moving average price of $71.22 and a two-hundred day moving average price of $69.28.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings results on Thursday, August 8th. The company reported $0.90 EPS for the quarter, topping the consensus estimate of $0.86 by $0.04. Prestige Consumer Healthcare had a net margin of 18.43% and a return on equity of 12.55%. The company had revenue of $267.10 million during the quarter, compared to analysts’ expectations of $260.54 million. During the same quarter in the previous year, the company earned $1.06 EPS. Prestige Consumer Healthcare’s revenue was down 4.4% on a year-over-year basis. As a group, equities analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.43 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

PBH has been the subject of several analyst reports. Jefferies Financial Group reissued a “hold” rating and set a $76.00 price target (up from $70.00) on shares of Prestige Consumer Healthcare in a report on Tuesday, September 24th. DA Davidson lifted their price target on shares of Prestige Consumer Healthcare from $93.00 to $95.00 and gave the company a “buy” rating in a report on Wednesday, August 28th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $94.20.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.